Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
In vitro compound screen against RSV clinical isolate strains
Request a Protocol
Ask a
question
Favorite
RSV clinical isolates were obtained from Baylor University and Medical College of Wisconsin. MOI of 0.1 used for all clinical isolates except RSV-A 629-9-2 (0.01) and RSV-B 629-24/2007 (0.0044) due to low titer. Virospot reduction assay was run by ViroClinics (Rotterdam, the Netherlands) against 20 additional RSV clinical isolates [44,45].
Copyright and License information: ©2021 Rhodin et al
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
